Impaired Decision-Making and the Role of Dopamine in Modulating Executive Function in Parkinson’s Disease

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1053226

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Patients with Parkinson’s Disease (PD) often experience significant impairments in their ability to make decisions, even in the earliest stages of the disease. This project will use a combination of psychophysics, pharmacotherapy and functional neuroimaging to examine the decision-making impairments that occur in PD, and how they are modulated by dopamine. We anticipate our findings will lead to improvements in the diagnosis and management of the syndromes of executive dysfunction seen in PD.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2016

Funding Scheme: Early Career Fellowships

Funding Amount: $390,468.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Decision Making

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Gaucher disease | Parkinson disease | attention | decision making | dopamine | eye movements | functional magnetic resonance imaging (fMRI) | psychophysics | transcranial magnetic stimulation (TMS) | working memory

Related Links